2022-RA-1674-ESGO Should delayed debulking/cytoreductive surgery be offered to all advanced ovarian/fallopian tubal cancer patients that did not have surgery?

Natasha D Souza; Eva Myriokefalitaki; Katelijn Sap; Alvin Michael Floreskou; Meghna Datta; Richard J Slade; Brett Winter-Roach; Michael Smith; Jurjees Hasan

doi:10.1136/ijgc-2022-ESGO.772

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About

YouTube

Podcasts

Zoom Journal Club
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals